These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 34893068)
1. Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology. Sheng X; Yao Y; Huang R; Xu Y; Zhu Y; Chen L; Zhang L; Wang W; Zhuo R; Can D; Chang CF; Zhang YW; Xu H; Bu G; Zhong L; Chen XF J Neuroinflammation; 2021 Dec; 18(1):286. PubMed ID: 34893068 [TBL] [Abstract][Full Text] [Related]
2. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model. Zhong L; Xu Y; Zhuo R; Wang T; Wang K; Huang R; Wang D; Gao Y; Zhu Y; Sheng X; Chen K; Wang N; Zhu L; Can D; Marten Y; Shinohara M; Liu CC; Du D; Sun H; Wen L; Xu H; Bu G; Chen XF Nat Commun; 2019 Mar; 10(1):1365. PubMed ID: 30911003 [TBL] [Abstract][Full Text] [Related]
3. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C; Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532 [TBL] [Abstract][Full Text] [Related]
4. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice. Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586 [TBL] [Abstract][Full Text] [Related]
5. Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Suárez-Calvet M; Araque Caballero MÁ; Kleinberger G; Bateman RJ; Fagan AM; Morris JC; Levin J; Danek A; Ewers M; Haass C; Sci Transl Med; 2016 Dec; 8(369):369ra178. PubMed ID: 27974666 [TBL] [Abstract][Full Text] [Related]
6. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model. Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586 [No Abstract] [Full Text] [Related]
7. Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study. Nabizadeh F; Seyedmirzaei H; Karami S Sci Rep; 2024 Jul; 14(1):15318. PubMed ID: 38961148 [TBL] [Abstract][Full Text] [Related]
8. Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ. Belsare KD; Wu H; Mondal D; Bond A; Castillo E; Jin J; Jo H; Roush AE; Pilla KB; Sali A; Condello C; DeGrado WF Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35082148 [TBL] [Abstract][Full Text] [Related]
9. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the Shi Q; Chang C; Saliba A; Bhat MA J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148 [TBL] [Abstract][Full Text] [Related]
10. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation. Moutinho M; Coronel I; Tsai AP; Di Prisco GV; Pennington T; Atwood BK; Puntambekar SS; Smith DC; Martinez P; Han S; Lee Y; Lasagna-Reeves CA; Lamb BT; Bissel SJ; Nho K; Landreth GE Genome Med; 2023 Feb; 15(1):11. PubMed ID: 36805764 [TBL] [Abstract][Full Text] [Related]
11. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice. Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z MAbs; 2022; 14(1):2107971. PubMed ID: 35921534 [TBL] [Abstract][Full Text] [Related]
12. Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation. Vilalta A; Zhou Y; Sevalle J; Griffin JK; Satoh K; Allendorf DH; De S; Puigdellívol M; Bruzas A; Burguillos MA; Dodd RB; Chen F; Zhang Y; Flagmeier P; Needham LM; Enomoto M; Qamar S; Henderson J; Walter J; Fraser PE; Klenerman D; Lee SF; St George-Hyslop P; Brown GC J Biol Chem; 2021; 296():100631. PubMed ID: 33823153 [TBL] [Abstract][Full Text] [Related]
13. Soluble TREM2 induces inflammatory responses and enhances microglial survival. Zhong L; Chen XF; Wang T; Wang Z; Liao C; Wang Z; Huang R; Wang D; Li X; Wu L; Jia L; Zheng H; Painter M; Atagi Y; Liu CC; Zhang YW; Fryer JD; Xu H; Bu G J Exp Med; 2017 Mar; 214(3):597-607. PubMed ID: 28209725 [TBL] [Abstract][Full Text] [Related]
14. Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology. Winfree RL; Nolan E; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Seto M; Petyuk VA; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ; Mol Neurodegener; 2024 May; 19(1):41. PubMed ID: 38760857 [TBL] [Abstract][Full Text] [Related]
15. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease. Zhang X; Tang L; Yang J; Meng L; Chen J; Zhou L; Wang J; Xiong M; Zhang Z Nat Commun; 2023 Oct; 14(1):6670. PubMed ID: 37865646 [TBL] [Abstract][Full Text] [Related]
16. Does Soluble TREM2 Protect Against Alzheimer's Disease? Brown GC; St George-Hyslop P Front Aging Neurosci; 2021; 13():834697. PubMed ID: 35153729 [TBL] [Abstract][Full Text] [Related]
17. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease. Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936 [TBL] [Abstract][Full Text] [Related]
18. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Ulrich JD; Finn MB; Wang Y; Shen A; Mahan TE; Jiang H; Stewart FR; Piccio L; Colonna M; Holtzman DM Mol Neurodegener; 2014 Jun; 9():20. PubMed ID: 24893973 [TBL] [Abstract][Full Text] [Related]
19. Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner. Zhou H; Li J; Hu L; Yu J; Fu X; Liang F; Yan F; Chen G J Adv Res; 2023 Feb; 44():185-199. PubMed ID: 36725189 [TBL] [Abstract][Full Text] [Related]
20. TREM2 ectodomain and its soluble form in Alzheimer's disease. Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]